Oral Nicotine Pouches and Public Health: Evidence from an Updated Scoping Review

Clicks: 1
ID: 327942
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #140 of 140 articles by views in nicotine & tobacco research : official journal of the society for research on nicotine and tobacco

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 140 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
INTRODUCTION: The popularity of oral nicotine pouches (ONPs) is rising in the US and worldwide. This review provides an update on their potential public health impact. METHODS: We searched six electronic databases for ONP-related empirical studies through September 30, 2025, updating an earlier review. Outcomes included ONP product characteristics, use patterns, beliefs, perceptions, toxicity, sales, and marketing. RESULTS: We identified 73 new studies published since our previous review (majority conducted in the US; 12 industry-funded). Data from heterogeneous national surveillance sources indicate a slow but steady increase in current ONP use prevalence among youth in 2024, with the National Youth Tobacco Survey (NYTS) reporting 1.8% prevalence among middle and high school students and the Monitoring the Future (MTF) study reporting 2.6% prevalence among 10th and 12th graders. Current use among adults was relatively low in 2022-2023 (0.4%-0.8%), with higher use among ages 18-44 and current tobacco users. US sales have more than tripled between 2021 and 2024. Marketing strategies increasingly emphasize potentially youth-appealing claims, with online and social media as key promotional channels. ONPs generally contain a higher proportion of freebase nicotine than other oral nicotine products and tobacco-containing pouches, with nicotine delivery increasing proportionally with nicotine strength. Nicotine uptake from higher strength ONPs (≥6mg) typically exceeds that from cigarettes in adult smokers, while ONPs consistently score lower in positive subjective ratings than cigarettes. Preliminary evidence from short-term, heterogeneous studies suggests that ONP use can reduce smoking in daily smokers, generally resulting in dual use rather than complete cigarette cessation. ONPs are considerably less toxic than cigarettes, but their long-term health impacts remain understudied. CONCLUSIONS: The review underscores the need for further research on ONP health effects, their efficacy in long-term smoking cessation, and broader public health impact in tobacco-naïve populations.
Reference Key
openalex_W7135178797 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Nargiz Travis, Kenneth E. Warner, Jamie Hartmann-Boyce, Maciej Ł. Goniewicz, Claire Ma, Rafael Meza, David T. Levy
Journal nicotine & tobacco research : official journal of the society for research on nicotine and tobacco
Year 2026
DOI
10.1093/ntr/ntag203
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.